Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs GANGA PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. GANGA PHARMACEUTICALS GENNEX LAB./
GANGA PHARMACEUTICALS
 
P/E (TTM) x 35.0 - - View Chart
P/BV x 4.5 2.2 208.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENNEX LAB.   GANGA PHARMACEUTICALS
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
GANGA PHARMACEUTICALS
Mar-23
GENNEX LAB./
GANGA PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs915 59.5%   
Low Rs58 61.7%   
Sales per share (Unadj.) Rs3.46.4 52.7%  
Earnings per share (Unadj.) Rs0.30.1 290.0%  
Cash flow per share (Unadj.) Rs0.30.2 139.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.513.4 33.9%  
Shares outstanding (eoy) m176.644.06 4,350.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.11.8 114.1%   
Avg P/E ratio x25.0119.5 20.9%  
P/CF ratio (eoy) x21.049.1 42.8%  
Price / Book Value ratio x1.50.9 177.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,22947 2,619.0%   
No. of employees `000NANA-   
Total wages/salary Rs m790 19,200.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m59326 2,295.0%  
Other income Rs m403 1,326.5%   
Total revenues Rs m63329 2,194.2%   
Gross profit Rs m470 93,860.0%  
Depreciation Rs m91 1,641.1%   
Interest Rs m142 697.9%   
Profit before tax Rs m641 12,024.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m150 10,371.4%   
Profit after tax Rs m490 12,617.9%  
Gross profit margin %7.90.2 4,322.9%  
Effective tax rate %22.826.1 87.5%   
Net profit margin %8.31.5 545.4%  
BALANCE SHEET DATA
Current assets Rs m48751 945.9%   
Current liabilities Rs m29519 1,557.4%   
Net working cap to sales %32.3125.8 25.7%  
Current ratio x1.62.7 60.7%  
Inventory Days Days4310 1.3%  
Debtors Days Days57,912,589125,511 46,141.4%  
Net fixed assets Rs m83528 2,943.1%   
Share capital Rs m18041 443.6%   
"Free" reserves Rs m62314 4,487.5%   
Net worth Rs m80455 1,474.3%   
Long term debt Rs m1636 2,565.0%   
Total assets Rs m1,32280 1,655.5%  
Interest coverage x5.71.3 448.2%   
Debt to equity ratio x0.20.1 174.0%  
Sales to assets ratio x0.40.3 138.6%   
Return on assets %4.72.9 162.7%  
Return on equity %6.10.7 849.1%  
Return on capital %8.04.1 197.2%  
Exports to sales %42.10-   
Imports to sales %13.60-   
Exports (fob) Rs m250NA-   
Imports (cif) Rs m81NA-   
Fx inflow Rs m2500-   
Fx outflow Rs m860-   
Net fx Rs m1640-   
CASH FLOW
From Operations Rs m2370 -59,190.0%  
From Investments Rs m-3835 -7,790.4%  
From Financial Activity Rs m210-4 -4,737.2%  
Net Cashflow Rs m640 70,900.0%  

Share Holding

Indian Promoters % 23.6 56.0 42.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 44.0 173.7%  
Shareholders   69,723 362 19,260.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs GANGA PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs GANGA PHARMACEUTICALS Share Price Performance

Period GENNEX LABORATORIES GANGA PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day 1.54% -4.98% 1.31%
1-Month -13.73% -5.20% -0.62%
1-Year 190.46% 87.77% 62.03%
3-Year CAGR 62.88% 59.64% 18.21%
5-Year CAGR 40.14% 32.40% 19.82%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the GANGA PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of GANGA PHARMACEUTICALS the stake stands at 56.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of GANGA PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

GANGA PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of GANGA PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.